A Clinical Study Evaluating the Efficacy and Safety of HRS-7249 in Treating Patients With Hyperlipidemia
A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 224 participants.
Also called NCT07100418
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 224 participants
- Registry
-
NCT07100418
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT07100418. Randomized; quadruple masking; primary purpose treatment. Start 2025-08-12 (actual); primary completion 2026-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Clinical Study Evaluating the Efficacy and Safety of HRS-7249 in Treating Patients With Hyperlipidemia
- Condition
- Hyperlipidemia
- Intervention (Drug)
- HRS-7249 Injection
- Intervention (Drug)
- Sodium Chloride Injection
- Lead sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd.
Record details
- Record id
cardio:ct-nct07100418- Content hash
9a3bcb2eaa6c493c0f3c3c43cdbbc65620e9ad9e3668bcb8642d54e3a9b8223f